Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC vs L-carnitine in Clomiphene-Resistant PCOS
NCT03164421Phase 2Completed
- Sponsor
- Zagazig University
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetylcysteine in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Zagazig University. Primary endpoint: Pregnancy rate at 3 months. Started Jan 2017; status: completed.
02
Drugs
acetylcysteine
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03164421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03164421.